A shortened activated partial thromboplastin time predicts thromboembolic risk in patients with newly diagnosed multiple myeloma

被引:0
|
作者
Carter, A. [1 ]
Rossini, F. [1 ]
Borella, C. [1 ]
Coccini, V [1 ]
Cammarota, S. [1 ]
Rossi, F. [2 ]
Poghani, E. M. [1 ]
机构
[1] Milano Bicocca Univ, Osped S Gerardo, Hematol & Bone Marrow Transplant Unit, Monza, Italy
[2] Milano Bicocca Univ, Osped S Gerardo, Immunotransfus Serv, Monza, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:136 / 136
页数:1
相关论文
共 50 条
  • [21] Substratification of Patients with Newly Diagnosed Standard-Risk Multiple Myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji K.
    BLOOD, 2017, 130
  • [22] Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma
    Tsai, Chun-Kuang
    Yeh, Chiu-Mei
    Hsu, Te-Lin
    Li, Chia-Ju
    Tin, Chian
    Hsiao, Liang-Tsai
    Liu, Yao-Chung
    Wang, Hao-Yuan
    Ko, Po-Shen
    Chen, Po-Min
    Liu, Jin-Hwang
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3991 - 3999
  • [23] Risk and Incidence of Venous Thromboembolism in Newly Diagnosed Multiple Myeloma Patients
    Nabar, Leeladhar
    Khan, Hamza
    Nair, Aditya
    Mishra, Dhyey
    Shah, Jash
    Lalwani, Devansh
    Talati, Shriraj
    Tembhare, Prashant
    Nayak, Lingaraj
    Shetty, Alok
    Rajpal, Sweta
    Chatterjee, Gaurav
    Khan, Ajmat
    Mirgh, Sumeet
    Jindal, Nishant
    Gokarn, Anant
    Punatar, Sachin
    Jain, Hasmukh
    Patkar, Nikhil
    Shetty, Dhanlaxmi
    Subramanian, Papagudi
    Gujral, Sumeet
    Bagal, Bhausaheb
    Sengar, Manju
    Khattry, Navin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S121 - S121
  • [24] Development of a Clinical Risk Stratification for Patients with Newly Diagnosed Multiple Myeloma
    Mao, Xuehan
    Xu, Yan
    Yan, Yuting
    Liu, Jiahui
    Fan, Huishou
    Sui, Weiwei
    Deng, Shuhui
    Li, Zengjun
    Qiu, Lugui
    An, Gang
    BLOOD, 2019, 134
  • [25] Determination of the individual infection risk for newly diagnosed patients with multiple myeloma
    Kaebisch, E.
    Heck, C.
    Frentsch, M.
    Blau, I. -W
    Nogai, A.
    Bullinger, L.
    Na, I. -K
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 48 - 48
  • [26] GERIATRIC ASSESSMENT PREDICTS SURVIVAL AND RISK OF SERIOUS ADVERSE EVENTS FOR ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Mina, R.
    Larocca, A.
    Offidani, M.
    Bringhen, S.
    La Fauci, A.
    Hajek, R.
    Montefusco, V.
    Brioli, A.
    Musolino, C.
    Falcone, A. P.
    Siniscalchi, A.
    Pautasso, C.
    Guglielmelli, T.
    Vincelli, I. D.
    Liberati, A. M.
    Muccio, V. E.
    Caraffa, P.
    Benevolo, G.
    Gentilini, F.
    Pulini, S.
    Pour, L.
    Musto, P.
    Petrucci, M. T.
    Sonneveld, P.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA, 2014, 99 : 105 - 106
  • [27] Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients
    Yan, Ge
    Li, Huangmin
    Zhang, Yiding
    Xia, Chenyan
    Wang, Mengxiao
    Jia, Yu
    Shang, Jin
    Zhao, Zhanzheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [29] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [30] Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values
    Zhao, Ying
    Zhang, Jie
    Zhang, Juanwen
    Wu, Jianping
    PLOS ONE, 2011, 6 (01):